Renal Cancer - Results from #3200

Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme. December 3, 2019

Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors. December 3, 2019

Evaluation to Differentiate between Tumor Lesions and the Parenchyma in Partial Nephrectomies for Renal Tumors Based on Quantitative Fluorescence Imaging Using Indocyanine Green Dye. December 2, 2019

The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications. December 2, 2019

A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis. December 2, 2019

Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma. November 29, 2019

Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop. November 29, 2019

Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy. November 29, 2019

The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. November 28, 2019

Rational Approaches to Treatment Duration with Immunotherapy in Metastatic Renal Cell Carcinoma. November 28, 2019

Sunitinib cause delayed complete response on metastatic RCC and extensive IVC thrombus, but not to the kidney tumor: a case report and review of literature. November 28, 2019

Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer. November 27, 2019

miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma. November 27, 2019

Treatment selection for first-line metastatic renal cell carcinoma in Australia: Impact of new therapy options. November 27, 2019

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival. November 26, 2019

Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma. November 26, 2019

Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer. November 26, 2019

Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes. November 25, 2019

Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma. November 25, 2019

New immunotherapy in the treatment of advanced renal cancer. November 25, 2019

Page 161 of 459